These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

10436 related items for PubMed ID: 18979999

  • 1. [Evolution of IGRA researches].
    Ariga H, Harada N.
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [Abstract] [Full Text] [Related]

  • 2. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
    Harada N.
    Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
    [Abstract] [Full Text] [Related]

  • 3. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S, Nagai H.
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [Abstract] [Full Text] [Related]

  • 4. Interferon gamma release assays: principles and practice.
    Lalvani A, Pareek M.
    Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):245-52. PubMed ID: 19783328
    [Abstract] [Full Text] [Related]

  • 5. Diagnosis of active tuberculous serositis by antigen-specific interferon-gamma response of cavity fluid cells.
    Ariga H, Kawabe Y, Nagai H, Kurashima A, Masuda K, Matsui H, Tamura A, Nagayama N, Akagawa S, Machida K, Hebisawa A, Nakajima Y, Yotsumoto H, Mori T.
    Clin Infect Dis; 2007 Dec 15; 45(12):1559-67. PubMed ID: 18190316
    [Abstract] [Full Text] [Related]

  • 6. [Effects of prophylaxis on QuantiFERON TB-2G responses among children].
    Higuchi K, Okada K, Harada N, Mori T.
    Kekkaku; 2008 Sep 15; 83(9):603-9. PubMed ID: 18979994
    [Abstract] [Full Text] [Related]

  • 7. [Research agenda of interferon-gamma release assays].
    Higuchi K, Harada N.
    Kekkaku; 2009 Apr 15; 84(4):173-86. PubMed ID: 19425393
    [Abstract] [Full Text] [Related]

  • 8. [Basic characteristics of a novel diagnostic method (QuantiFERON TB-2G) for latent tuberculosis infection with the use of Mycobacterium tuberculosis-specific antigens, ESAT-6 and CFP-10].
    Harada N, Higuchi K, Sekiya Y, Rothel J, Kitoh T, Mori T.
    Kekkaku; 2004 Dec 15; 79(12):725-35. PubMed ID: 15782618
    [Abstract] [Full Text] [Related]

  • 9. [A view of dynamics of immune responses against tuberculosis infection through QFT].
    Harada N.
    Kekkaku; 2011 Jul 15; 86(7):743-9. PubMed ID: 21922785
    [Abstract] [Full Text] [Related]

  • 10. [Application and problems of quantiFERON TB-2G for tuberculosis control programs--(2) clinical use of quantiFERON TB-2G].
    Kawabe Y.
    Kekkaku; 2007 Jan 15; 82(1):61-6. PubMed ID: 17310783
    [Abstract] [Full Text] [Related]

  • 11. [Comparison of interferon-gamma whole blood assay with tuberculin skin test for the diagnosis of tuberculosis infection in tuberculosis contacts].
    Oztürk N, Sürücüoğlu S, Ozkütük N, Gazi H, Akçali S, Köroğlu G, Ciçek C.
    Mikrobiyol Bul; 2007 Apr 15; 41(2):193-202. PubMed ID: 17682705
    [Abstract] [Full Text] [Related]

  • 12. [QFT test and TST test in diagnosis of TB infection].
    Higuchi K.
    Nihon Rinsho; 2011 Aug 15; 69(8):1378-83. PubMed ID: 21838033
    [Abstract] [Full Text] [Related]

  • 13. Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis.
    Detjen AK, Keil T, Roll S, Hauer B, Mauch H, Wahn U, Magdorf K.
    Clin Infect Dis; 2007 Aug 01; 45(3):322-8. PubMed ID: 17599309
    [Abstract] [Full Text] [Related]

  • 14. An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection.
    Codecasa L, Mantegani P, Galli L, Lazzarin A, Scarpellini P, Fortis C.
    J Clin Microbiol; 2006 Jun 01; 44(6):1944-50. PubMed ID: 16757583
    [Abstract] [Full Text] [Related]

  • 15. Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment.
    Kobashi Y, Mouri K, Yagi S, Obase Y, Miyashita N, Oka M.
    J Infect; 2009 Mar 01; 58(3):197-204. PubMed ID: 18848730
    [Abstract] [Full Text] [Related]

  • 16. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 01; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 17. QuantiFERON-TB Gold assay for the diagnosis of latent tuberculosis infection.
    Manuel O, Kumar D.
    Expert Rev Mol Diagn; 2008 May 01; 8(3):247-56. PubMed ID: 18598104
    [Abstract] [Full Text] [Related]

  • 18. Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis.
    Mazurek GH, Weis SE, Moonan PK, Daley CL, Bernardo J, Lardizabal AA, Reves RR, Toney SR, Daniels LJ, LoBue PA.
    Clin Infect Dis; 2007 Oct 01; 45(7):837-45. PubMed ID: 17806047
    [Abstract] [Full Text] [Related]

  • 19. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients.
    Triverio PA, Bridevaux PO, Roux-Lombard P, Niksic L, Rochat T, Martin PY, Saudan P, Janssens JP.
    Nephrol Dial Transplant; 2009 Jun 01; 24(6):1952-6. PubMed ID: 19164327
    [Abstract] [Full Text] [Related]

  • 20. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens.
    Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, Shigeto E, Harada N, Mitarai S, Okada M, Suzuki K, Inoue Y, Tsuyuguchi K, Sasaki Y, Mazurek GH, Tsuyuguchi I.
    Am J Respir Crit Care Med; 2004 Jul 01; 170(1):59-64. PubMed ID: 15059788
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 522.